Real-world experience with MMX mesalazine use in Mexican patients with ulcerative colitis at two tertiary care centers

Autor: J.K. Yamamoto-Furusho, N.N. Parra-Holguín

Publikováno v: Revista de Gastroenterología de México (English Edition), Vol 87, Iss 3, Pp 305-311 (2022)

Introduction and aims: The 5-aminosalicylates, especially mesalazine, are the first option in the treatment of mild-to-moderate ulcerative colitis (UC). High rates of remission induction and maintenance have been observed with the new multimatrix (MM

Externí odkaz: https://doaj.org/article/ed2b5a99f6c7458291b0a3131061adb3

Mesalazina administrada de forma tópica como causa de síndrome de Stevens-Johnson

Autor: Andrea Núñez-Ortiz, Claudio Trigo-Salado, María-Dolores de-la-Cruz-Ramírez, José-Manuel Herrera-Justiniano, Eduardo Leo-Carnerero

Publikováno v: Revista Espanola de Enfermedades Digestivas, Vol 110, Iss 11, Pp 736-738 (2018)

RESUMEN La mesalazina es un fármaco usado habitualmente en la colitis ulcerosa que suele cursar con pocos efectos secundarios. Se han descrito casos infrecuentes de lesiones mucocutáneas graves como el síndrome de Stevens-Johnson (SSJ) y la necró

Externí odkaz: https://doaj.org/article/dced8249ae9846598a1816d5b4fbbf9b

Development of mesalazine pellets coated with methacrylic-derived polymer

Autor: Simone Cristina Déo, Itamar Francisco Andreazza, João Carlos Possamai

Publikováno v: Brazilian Journal of Pharmaceutical Sciences, Vol 47, Iss 1, Pp 103-109 (2011)

Mesalazine (5-ASA) is the standard drug for the treatment of inflammatory bowel disease (IBD) due to its local effect on intestinal and colonic mucosa. The effective and safe treatment of this disease requires more efficient delivery of the active su

Externí odkaz: https://doaj.org/article/2b282f0871f9453e9f110f7ab2bade12

Micropartículas de xilana contendo mesalazina visando a liberação no cólon

Autor: Urtiga, Silvana Cartaxo da Costa

Publikováno v: Repositório Institucional da UFRN
Universidade Federal do Rio Grande do Norte (UFRN)
instacron:UFRN

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES A xilana é um importante biopolímero que pode ser extraído de vários resíduos agrícolas e tem recebido grande atenção no desenvolvimento de sistemas de liberação de fá

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3056::1d34b28bc2895d4dfde0d76f8e84bedd
https://repositorio.ufrn.br/handle/123456789/32219

Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on topical therapy in ulcerative colitis

Autor: Ginard, D, Marin-Jimenez, I, Barreiro-de Acosta, M, Ricart, E, Domenech, E, Gisbert, JP, Esteve, M, Minguez, M, Representacion GETECCU

Publikováno v: Gastroenterologia y Hepatologia
r-IGTP: Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Universidad de Alicante (UA)
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname

Although most patients with ulcerative colitis should be given topical treatment, different studies have shown that they are underused in clinical practice. The purpose of this article is to answer 10 specific questions about which drugs are availabl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f94c1ada8eec3a0295feb4c9ed237ab
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=1224